Leafwell Advances Medical Cannabis as Clinically Validated Solution for Cancer-Related Symptoms and Chronic Pain, Supports Employer-Sponsored Mental Health BenefitsCHICAGO, May 20, 2026 (GLOBE NEWSWIRE) -- Leafwell, the category-defining platform for employer-sponsored medical cannabis, is calling upon stakeholders across the self-insured ecosystem to recognize physician-led medical cannabis as a mainstream alternative to high-cost care pathways for oncology, chronic pain management, sleep disorders and beyond. With 700,000+ patients served and peer-reviewed evidence in hand, Leafwell delivers HIPAA-compliant physician telehealth consultations, personalized treatment plans and ongoing clinical support designed to improve outcomes while potentially reducing healthcare spend.
